当前位置:首页 - 行情中心 - 睿智医药(300149) - 财务分析 - 资产负债表

睿智医药

(300149)

  

流通市值:27.54亿  总市值:27.59亿
流通股本:4.99亿   总股本:5.00亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金294,169,260.64263,293,292.89343,159,149.37761,664,274.51
应收票据及应收账款296,500,306.07326,000,896.15330,079,324.2341,494,608.74
应收账款296,500,306.07326,000,896.15330,079,324.2341,494,608.74
预付款项12,687,240.4821,761,186.4314,448,509.2716,057,061.2
其他应收款合计87,216,163.5890,047,823.2683,958,744.9687,182,373.09
存货60,529,369.837,495,645.4853,296,064.7242,816,581.17
合同资产16,500,735.1216,902,179.9510,726,133.178,379,153.51
其他流动资产39,775,832.4534,411,934.1525,400,794.9922,765,360.14
流动资产平衡项目0000
流动资产合计813,578,908.14805,512,958.31869,398,720.681,280,359,412.36
非流动资产:
长期股权投资231,760,325.61230,713,641.91219,567,451.73197,017,953.01
其他权益工具投资--2,296,500-
其他非流动金融资产1,931,550.742,047,283.41-2,296,500
投资性房地产27,448,026.5722,280,910.5613,201,628.1814,185,186.11
固定资产499,101,457489,476,156.68380,401,653.2374,538,085.14
在建工程48,095,287.8154,677,903.46162,236,044.1575,357,552.79
使用权资产483,157,476.93503,133,514.04504,152,279.24523,721,695.83
无形资产49,361,800.5354,384,539.2654,918,893.8955,655,763.12
商誉858,860,380.19858,860,380.19858,860,380.19858,860,380.19
长期待摊费用353,890,675.81355,212,595.82360,258,439.13370,233,421.38
递延所得税资产9,748,628.0910,914,523.917,105,845.8410,662,359.48
其他非流动资产34,189,746.3143,551,549.4140,327,397.7361,008,832.3
非流动资产平衡项目0000
非流动资产合计2,597,545,355.592,625,252,998.642,613,326,513.282,543,537,729.35
资产平衡项目0000
资产总计3,411,124,263.733,430,765,956.953,482,725,233.963,823,897,141.71
流动负债:
短期借款60,002,611.0860,002,611.0895,022,611.08115,022,611.12
应付票据及应付账款56,071,915.6655,827,922.7188,562,265.4480,698,134.74
应付账款56,071,915.6655,827,922.7188,562,265.4480,698,134.74
合同负债99,695,612.9396,146,185.7384,562,23874,481,318.46
应付职工薪酬50,310,132.7741,783,737.8530,547,632.7266,836,380.46
应交税费6,511,456.994,827,398.3117,966,450.6551,699,989.69
其他应付款合计159,169,147.6150,510,926.42175,805,153.97162,587,357.65
一年内到期的非流动负债70,189,707.0378,838,535.0993,774,673.66178,709,245.73
其他流动负债1,359,566.651,959,788.42,239,380.571,995,899.67
流动负债平衡项目0000
流动负债合计503,310,150.71489,897,105.59588,480,406.09732,030,937.52
非流动负债:
长期借款47,083,90041,015,00019,281,110.07177,209,980.14
租赁负债474,000,601.47491,868,854.66491,913,726.72495,253,209.94
预计负债5,187,310.345,132,383.715,078,038.685,024,269.09
递延收益17,038,957.0215,844,550.9416,185,072.9216,410,349.68
递延所得税负债9,889,629.4713,106,200.039,835,635.0212,007,088.29
非流动负债平衡项目0000
非流动负债合计553,200,398.3566,966,989.34542,293,583.41705,904,897.14
负债平衡项目0000
负债合计1,056,510,549.011,056,864,094.931,130,773,989.51,437,935,834.66
所有者权益(或股东权益):
实收资本(或股本)499,776,892499,776,892499,776,892499,776,892
资本公积1,229,187,219.211,229,187,219.211,229,187,219.211,229,187,219.21
减:库存股25,506,290.2425,506,290.2425,506,290.2425,506,290.24
其他综合收益19,814,715.7919,598,677.414,398,391.039,812,857.48
盈余公积169,649,539.17169,649,539.17169,649,539.17169,649,539.17
未分配利润437,412,016.91456,839,877.25450,048,872.03478,615,783.69
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计2,330,334,092.842,349,545,914.82,327,554,623.22,361,536,001.31
少数股东权益24,279,621.8824,355,947.2224,396,621.2624,425,305.74
股东权益平衡项目0000
股东权益合计2,354,613,714.722,373,901,862.022,351,951,244.462,385,961,307.05
负债和股东权益合计3,411,124,263.733,430,765,956.953,482,725,233.963,823,897,141.71
公告日期2023-10-252023-08-292023-04-272023-04-27
审计意见(境内)标准无保留意见
TOP↑